KR940005284A - 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법 - Google Patents

면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법 Download PDF

Info

Publication number
KR940005284A
KR940005284A KR1019930007716A KR930007716A KR940005284A KR 940005284 A KR940005284 A KR 940005284A KR 1019930007716 A KR1019930007716 A KR 1019930007716A KR 930007716 A KR930007716 A KR 930007716A KR 940005284 A KR940005284 A KR 940005284A
Authority
KR
South Korea
Prior art keywords
plasminogen activator
activator inhibitor
immunoaffinity chromatography
pai
purification method
Prior art date
Application number
KR1019930007716A
Other languages
English (en)
Inventor
혹크 요한
Original Assignee
스타인. 하아스
베링베르케 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스타인. 하아스, 베링베르케 아크티엔게젤샤프트 filed Critical 스타인. 하아스
Publication of KR940005284A publication Critical patent/KR940005284A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04LTRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00Packet switching elements
    • H04L49/10Packet switching elements characterised by the switching fabric construction
    • H04L49/102Packet switching elements characterised by the switching fabric construction using shared medium, e.g. bus or ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8132Plasminogen activator inhibitors
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04LTRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00Packet switching elements
    • H04L49/10Packet switching elements characterised by the switching fabric construction
    • H04L49/103Packet switching elements characterised by the switching fabric construction using a shared central buffer; using a shared memory
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04LTRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00Packet switching elements
    • H04L49/30Peripheral units, e.g. input or output ports
    • H04L49/3027Output queuing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 면역친화성 크로마토그래피에 의해 플라스미노겐 활성화제 억제제 2 (PAI-2)를 정제하는 방법 및 이러한 타입의 방법을 위해 적합한 모노클로날 항체에 관한 것이다.

Description

면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. PA1-2를 함유하는 용액을 지지체 물질(친화성 물질)에 결합된, PAI-2에 대한 모노클로날 항체와 접촉시키고, 친화성 물질 및 액체를 서로로부터 분리시키고, 친화성 물질로부터 PAI-2를 생물학적 활성 형태로 용출시킴을 특징으로하여, 면역친화성 크로마토그래피에 의해 순수한 플라스미노겐 활성화제 억제제2(PAI-2)를 생물학적 활성 형태로 수득하는 방법.
  2. 제1항에 있어서, 모노클로날 항체의 면역반응성 단편 또는 유도체가 지지체 물질에 결합된 방법.
  3. 제1항에 있어서,pH 5.5 내지 8.5에서 전도성이 3mS미만인 완충액 또는 증류수를 사용하여 용출을 수행하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930007716A 1992-05-06 1993-05-06 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법 KR940005284A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4214999.1 1992-05-06
DE4214999A DE4214999C2 (de) 1992-05-06 1992-05-06 Reinigung von Plasminogen-Aktivator-Inhibitor 2 durch Immunaffinitätschromatographie

Publications (1)

Publication Number Publication Date
KR940005284A true KR940005284A (ko) 1994-03-21

Family

ID=6458317

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019930007717A KR930024353A (ko) 1992-05-06 1993-05-06 고속 패킷 교환기
KR1019930007716A KR940005284A (ko) 1992-05-06 1993-05-06 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019930007717A KR930024353A (ko) 1992-05-06 1993-05-06 고속 패킷 교환기

Country Status (12)

Country Link
US (1) US5362857A (ko)
EP (1) EP0568836A1 (ko)
JP (1) JPH069695A (ko)
KR (2) KR930024353A (ko)
AU (1) AU3837193A (ko)
CA (1) CA2095577A1 (ko)
DE (1) DE4214999C2 (ko)
IL (1) IL105610A0 (ko)
MX (1) MX9302629A (ko)
NO (1) NO931629L (ko)
NZ (1) NZ247533A (ko)
ZA (1) ZA932443B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049887A1 (en) 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134065A (en) * 1986-05-16 1992-07-28 Monsanto Company Tissue plasminogen activator inhibitor and method of purification
DE3713272A1 (de) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogenaktivator-inhibitor, typ 2 (pai-2)
DE3929504A1 (de) * 1989-09-06 1991-03-07 Behringwerke Ag Verfahren zur reinigung von plasminogen-aktivator-inhibitor 2 (pai-2)
US5204256A (en) * 1989-09-06 1993-04-20 Behringwerke Aktiengesellschaft Process for the purification of plasminogen activator inhibitor 2 (pai-2)
EP0458937B1 (en) * 1989-12-20 1997-08-13 Biotech Australia Pty. Limited Variants of pai-2

Also Published As

Publication number Publication date
EP0568836A1 (de) 1993-11-10
KR930024353A (ko) 1993-12-22
MX9302629A (es) 1993-11-01
DE4214999A1 (de) 1993-11-11
NO931629L (no) 1993-11-08
CA2095577A1 (en) 1993-11-07
IL105610A0 (en) 1993-09-22
NO931629D0 (no) 1993-05-05
AU3837193A (en) 1993-11-11
US5362857A (en) 1994-11-08
DE4214999C2 (de) 1994-07-14
NZ247533A (en) 1994-12-22
JPH069695A (ja) 1994-01-18
ZA932443B (en) 1993-10-20

Similar Documents

Publication Publication Date Title
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
PT1308455E (pt) Composicao compreendendo anticorpos anti-her2
DK0746398T3 (da) Antistofrensning
ATE213639T1 (de) Proteinreinigung
ATE425989T1 (de) Proteinreinigungsverfahren
ES8100502A1 (es) Un procedimiento para purificar proteinas con pesos moleculares superiores a 12.000,en particular interferon
NO172596C (no) Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer, anvendelse av disse og diagnostiske systemer inneholdende disse
KR940027658A (ko) 트롬빈 결합성 물질 및 이의 제조방법
JOSIĆ et al. Purification of monoclonal antibodies by hydroxylapatite HPLC and size exclusion HPLC
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
KR940005284A (ko) 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법
DE69637464D1 (de) Therapeutische fragmente des "von willebrand" faktors
ATE237636T1 (de) Reinigung von molekülen
KR930004476A (ko) 인자(xiii)의 정제방법, 인자(xiiia)에 대한 모노클로날 항체, 이의 제조방법 및 용도
CA2145005A1 (en) Monoclonal antibodies specific for tcf-ii
FR2663816B1 (fr) Procede de traitement du colostrum par chromatographie d'adsorption sur hydroxyapatite, fraction active de colostrum obtenue et milieu cellulaire contenant ladite fraction active.
KR910018041A (ko) Pp4에 대한 모노클로날 항체, 이의 제조방법 및 용도
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
KR910015699A (ko) 리포코틴의 정제방법
KR940019857A (ko) 유로키나제의 정제 방법
DE69415664D1 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
KR900018369A (ko) 사람의 응모성 성선 호르몬의 정제 방법
KR950003823A (ko) 인체 표피 성장 인자의 정제시 hplc를 이용한 순도 분석방법
MY102245A (en) Purification of antibodies
KR880001805A (ko) 조 임파구 인터페론의 정제방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid